161 related articles for article (PubMed ID: 4575294)
21. [A morphologic study of the harmlessness of live dysentery vaccines from streptomycin dependent mutants of Sh. flexneri].
Levenbuk IS; Sergeev VV; Elkina SI; Kavtaradze KN; Dzhikidze EK
Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):18-22. PubMed ID: 4623775
[No Abstract] [Full Text] [Related]
22. Correlation between Congo red binding and contact haemolysin production in Shigella species.
Sharma K; Rishi P; Grewal JS; Ram S; Tiwari RP
Microbios; 2001; 106(413):31-8. PubMed ID: 11491522
[TBL] [Abstract][Full Text] [Related]
23. Bacteriological and epidemiological approach to prophylaxy for enteric infection. IV. Experimental bladder infection of Shigella.
Anzai H; Kubota Y; Okamoto M; Sekizuka S; Nakamura T
Kitasato Arch Exp Med; 1971 Dec; 44(3):155-66. PubMed ID: 4949632
[No Abstract] [Full Text] [Related]
24. Identification and molecular characterization of a 27 kDa Shigella flexneri invasion plasmid antigen, IpaJ.
Buysse JM; Dunyak DS; Hartman AB; Venkatesan MM
Microb Pathog; 1997 Dec; 23(6):357-69. PubMed ID: 9441862
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of butorphanol tartrate and buprenorphine hydrochloride on the inflammatory reaction of the Sereny Test.
Swearengen JR; Cockman-Thomas RA; Davis JA; Weina PJ
Lab Anim Sci; 1993 Oct; 43(5):471-5. PubMed ID: 8277729
[TBL] [Abstract][Full Text] [Related]
26. Studies on the energetic metabolism of Shigella flexneri x Escherichia coli hybrids devoid of penetration ability. IV. Growth characteristics in the presence of some tricarboxylic acid cycle intermediates.
Radoutcheva T; Veljanov D; Bondarenko VM
Zentralbl Bakteriol Orig A; 1976 Oct; 236(1):99-104. PubMed ID: 793258
[TBL] [Abstract][Full Text] [Related]
27. [On the genetics of pathogenicity for mucosa of dysentery bacilli].
Stenzel W
Zentralbl Bakteriol Orig; 1971; 216(1):67-78. PubMed ID: 4928071
[No Abstract] [Full Text] [Related]
28. [Study of the virulence of Shigella in the reaction with tripaflavin with the aid of kertoconjunctival test].
Mirzoev GG; Ivanova TN
Lab Delo; 1975; (3):176-7. PubMed ID: 48599
[No Abstract] [Full Text] [Related]
29. [The virulence of Sh. flexneri hybrids obtained by crossing with different strains of E. coli K-12 Hfr].
Petrovskaia VG; Lycheva TA
Zh Mikrobiol Epidemiol Immunobiol; 1970 May; 47(5):42-7. PubMed ID: 4917063
[No Abstract] [Full Text] [Related]
30. A study on experimental keratoconjunctivitis shigellosa.
Okamoto M
Kitasato Arch Exp Med; 1980 Dec; 53(3-4):81-96. PubMed ID: 7035740
[No Abstract] [Full Text] [Related]
31. Involvement of a plasmid in the invasive ability of Shigella flexneri.
Sansonetti PJ; Kopecko DJ; Formal SB
Infect Immun; 1982 Mar; 35(3):852-60. PubMed ID: 6279518
[TBL] [Abstract][Full Text] [Related]
32. Effects of buprenorphine on immunogenicity and protective efficacy in the guinea pig keratoconjunctivitis model (Sereny test).
Hanson CE; Ruble GR; Essiet I; Hartman AB
Comp Med; 2001 Jun; 51(3):224-9. PubMed ID: 11924776
[TBL] [Abstract][Full Text] [Related]
33. [Construction and characterization of a live attenuated Shigella flexneri 2a vaccine strain, sf301 Delta virG and dsbA33G].
Yang XF; Zhou L; Zheng J; Si LS; Wang YL
Wei Sheng Wu Xue Bao; 2005 Oct; 45(5):748-52. PubMed ID: 16342769
[TBL] [Abstract][Full Text] [Related]
34. SALICIN-FERMENTING VARIANT OF SHIGELLA FLEXNERI SEROTYPE 2A.
KEREKES L
Acta Microbiol Acad Sci Hung; 1965; 12():7-13. PubMed ID: 14345179
[No Abstract] [Full Text] [Related]
35. [The loss in pathogenicity for mucosa of dysentery bacteria in vitro].
Stenzel W
Zentralbl Bakteriol Orig; 1971; 216(1):54-66. PubMed ID: 4928070
[No Abstract] [Full Text] [Related]
36. [Conjugation of E. Coli P4x and Shigella flexneri 2a. II. Production of S. flexneri Hfr strain].
Zaleska H; Janczura E; Stypulkowska-Misiurewicz
Med Dosw Mikrobiol; 1970; 22(2):119-23. PubMed ID: 4913813
[No Abstract] [Full Text] [Related]
37. Immunogenicity of living attenuated shigellae.
Serény B; Tenner C; Rácz P
Acta Microbiol Acad Sci Hung; 1971; 18(4):239-45. PubMed ID: 4950775
[No Abstract] [Full Text] [Related]
38. [The pathogenic properties of streptomycin-dependent mutants of Sh. flexneri and its revertants].
Mikhaĭlov IF; Sergeev VV; Elkina SI
Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):10-4. PubMed ID: 5735219
[No Abstract] [Full Text] [Related]
39. [Intraspecies antagonism of Sh. flexneri in an HEp-2 cell line model].
Bondarenko VM; Iuditskaia NM; Petrovskaia VG
Zh Mikrobiol Epidemiol Immunobiol; 1977 Jun; (6):115-9. PubMed ID: 331774
[TBL] [Abstract][Full Text] [Related]
40. [Laboratory safety testing of live dysentery vaccine strains (author's transl)].
Lesniak SV; Levenbuk IS; Fedotova Y; Belaya M; Yu A; Sergeev VV; Jikidze EK; Kavtaradze KN; Elkina SL
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):87-97. PubMed ID: 4216254
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
